From Pathophysiology to Novel Therapeutic Approaches in Alzheimer’s Disease
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".
Deadline for manuscript submissions: 31 May 2025 | Viewed by 20
Special Issue Editor
Interests: Alzheimer's disease; neurodegeneration; vascular disease; acute care; critically ill patient
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Alzheimer's disease (AD) is a very complex disease affecting millions of people worldwide and representing the first cause of cognitive deterioration and dementia. Despite the advances in research and therapeutics, the prevalence of this condition is increasing, and treatments are still poorly effective in preventing but also avoiding disease progression. Several pathophysiological mechanisms have been suggested in recent years, and novel therapeutic approaches, such as specific anti-Ab monoclonal antibodies, have been introduced in clinical practice.
With this Special Issue of Biomedicines, we aim to provide novel insights into the AD pathophysiology of Alzheimer's disease, exploring the underlying mechanisms and processes involved in the development and progression of the condition. We also aim to discuss current and emerging treatment strategies, including pharmacological and non-pharmacological interventions. We will consider original research articles as well as systematic and narrative reviews on the topics covered by this Special Issue.
Thank you for considering this invitation, and I look forward to your valuable contributions to this collaborative effort.
Warm regards,
Dr. Lorenzo Falsetti
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Alzheimer's disease
- neurodegeneration
- cognitive deterioration
- dementia
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
